IE831267L - Compostions containing salbutamol - Google Patents
Compostions containing salbutamolInfo
- Publication number
- IE831267L IE831267L IE831267A IE126783A IE831267L IE 831267 L IE831267 L IE 831267L IE 831267 A IE831267 A IE 831267A IE 126783 A IE126783 A IE 126783A IE 831267 L IE831267 L IE 831267L
- Authority
- IE
- Ireland
- Prior art keywords
- salbutanol
- pref
- cellulose
- amt
- esp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
New medicaments are aq. dispersions of one or more cellulose derivs. contg. salbutanol and/or one or more physiologically acceptable salts of salbutanol. Suitable cellulose derivs. are those which form an optically transparent or opalescent dispersion in water. Particularly pref. are ethylcellulose, methylcellulose, ethylmethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxyethyl methylcellulose, hydroxypropylmethylcellulose, hydroxyethyl-ethyl cellulose and carboxymethyl cellulose and its salts. The cellulose deriv. is pref. used in a total amt. of at least 0.1% w/v. For oral formulations, the cellulose deriv. is pref. present in an amt. such as to give a viscosity of 5-10000 (esp. 10-100) cPs. Salbutanol or its salt is pref. present in an amt. of 1-4 (esp.2) mg. per 5 ml., expressed as salbutanol free base. The prepn. pref. has a pH of 3.5. Salbutanol is a beta-stimulant with improved stability.
[FR2527442A1]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8215502 | 1982-05-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE831267L true IE831267L (en) | 1983-11-27 |
IE55139B1 IE55139B1 (en) | 1990-06-06 |
Family
ID=10530673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1267/83A IE55139B1 (en) | 1982-05-27 | 1983-05-27 | Compositions containing salbutamol |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPH0629181B2 (en) |
AT (1) | AT390191B (en) |
AU (1) | AU567675B2 (en) |
BE (1) | BE896870A (en) |
CA (1) | CA1203176A (en) |
CH (1) | CH656308A5 (en) |
DE (1) | DE3319356C2 (en) |
DK (1) | DK167558B1 (en) |
ES (1) | ES8502336A1 (en) |
FI (1) | FI81257C (en) |
FR (1) | FR2527442B1 (en) |
GR (1) | GR82681B (en) |
IE (1) | IE55139B1 (en) |
IL (1) | IL68805A0 (en) |
IT (1) | IT1174759B (en) |
LU (1) | LU84828A1 (en) |
MY (1) | MY8700275A (en) |
NL (1) | NL192663C (en) |
NO (1) | NO163166C (en) |
NZ (1) | NZ204385A (en) |
PH (1) | PH19601A (en) |
PT (1) | PT76773B (en) |
SE (1) | SE454946B (en) |
ZA (1) | ZA833854B (en) |
ZW (1) | ZW11883A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3624213A (en) * | 1963-10-30 | 1971-11-30 | Merck & Co Inc | Method of sterilizing aqueous pharmaceutical solutions employing propylene oxide and entrained air |
GB1200886A (en) * | 1966-09-23 | 1970-08-05 | Allen & Hanburys Ltd | Phenylaminoethanol derivatives |
GB1453034A (en) * | 1972-12-15 | 1976-10-20 | Boehringer Sohn Ingelheim | Pharmaceutical composition for treating spasticity |
JPS5831210B2 (en) * | 1973-04-09 | 1983-07-05 | 武田薬品工業株式会社 | antennae |
DE2714065A1 (en) * | 1977-03-30 | 1978-10-12 | Boehringer Mannheim Gmbh | INSTILLATION PREPARATION |
-
1983
- 1983-05-20 CH CH2779/83A patent/CH656308A5/en not_active IP Right Cessation
- 1983-05-24 GR GR71454A patent/GR82681B/el unknown
- 1983-05-26 NO NO831875A patent/NO163166C/en not_active IP Right Cessation
- 1983-05-26 FR FR8308722A patent/FR2527442B1/en not_active Expired
- 1983-05-27 PT PT76773A patent/PT76773B/en unknown
- 1983-05-27 CA CA000429095A patent/CA1203176A/en not_active Expired
- 1983-05-27 PH PH28974A patent/PH19601A/en unknown
- 1983-05-27 DK DK241783A patent/DK167558B1/en not_active IP Right Cessation
- 1983-05-27 LU LU84828A patent/LU84828A1/en unknown
- 1983-05-27 IE IE1267/83A patent/IE55139B1/en not_active IP Right Cessation
- 1983-05-27 SE SE8303012A patent/SE454946B/en not_active IP Right Cessation
- 1983-05-27 JP JP58093896A patent/JPH0629181B2/en not_active Expired - Lifetime
- 1983-05-27 IT IT48384/83A patent/IT1174759B/en active Protection Beyond IP Right Term
- 1983-05-27 IL IL68805A patent/IL68805A0/en not_active IP Right Cessation
- 1983-05-27 AU AU15039/83A patent/AU567675B2/en not_active Expired
- 1983-05-27 DE DE3319356A patent/DE3319356C2/en not_active Expired - Lifetime
- 1983-05-27 NL NL8301900A patent/NL192663C/en not_active IP Right Cessation
- 1983-05-27 NZ NZ204385A patent/NZ204385A/en unknown
- 1983-05-27 BE BE0/210866A patent/BE896870A/en not_active IP Right Cessation
- 1983-05-27 ZA ZA833854A patent/ZA833854B/en unknown
- 1983-05-27 ZW ZW118/83A patent/ZW11883A1/en unknown
- 1983-05-27 ES ES522752A patent/ES8502336A1/en not_active Expired
- 1983-05-27 AT AT0195283A patent/AT390191B/en not_active IP Right Cessation
- 1983-05-27 FI FI831893A patent/FI81257C/en not_active IP Right Cessation
-
1987
- 1987-12-30 MY MY275/87A patent/MY8700275A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100319351B1 (en) | Bilayer Oxavabazepine Tablets | |
HK12495A (en) | Pharmaceutical formulations | |
IE882709L (en) | Sustained release etodolac | |
FR2613224B1 (en) | EXTENDED RELEASE BILAYER DOSAGE FORM | |
ES2096781T3 (en) | COMPOSITIONS OF CONTROLLED RELEASE OXICODONS. | |
GB8626098D0 (en) | Controlled release hydromorphone composition | |
ES8303091A1 (en) | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration | |
ES8608864A1 (en) | Sheet-like preparation | |
CA2198917A1 (en) | Sustained release of peptides from pharmaceutical compositions | |
IE970588A1 (en) | Controlled release pharmaceutical compositions containing tiagabine | |
KR100257803B1 (en) | Stable hydrated cephalosporin dry powder for oral suspension formulation | |
ES8609325A1 (en) | Derivatives of Guanine, process for their preparation and a pharmaceutical preparation. | |
GB1465347A (en) | Composition | |
CA2136404A1 (en) | Mucoadhesive, therapeutic or hygienic solid composition for application on oral or nasal mucosa | |
CA2057291A1 (en) | A stable pharmaceutical composition of human calcitonin | |
IE831267L (en) | Compostions containing salbutamol | |
JP2634436B2 (en) | Topical ophthalmic composition containing lambsan gum | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
JP2003514014A5 (en) | ||
US3122578A (en) | Complexes of tetracycline antibiotics and preparation of same | |
ES2004807A6 (en) | Nasal compsn. contg. octreotide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |